AIG vs TSHA · P/E 21, rev $13.73B vs $640.7M cap
American International Group Inc (AIG) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
American International Group Inc (AIG) is a insurance - diversified company listed on US.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
Latest reported AIG revenue for 2026-06-30 was $13.73B. Net income was $1.71B. AIG currently screens at market cap $48.97B and trailing P/E 20.6.
Latest reported TSHA revenue for 2026-06-30 was $0. Net income was -$89.0M. TSHA currently screens at market cap $640.7M.
AIG currently screens at market cap $48.97B and trailing P/E 20.6. TSHA currently screens at market cap $640.7M.
Not investment advice. Open the AIG and TSHA stock pages for the full models.
Not investment advice.